Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans (PURSUIT)

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Enrolling

Conditions

Urinary Incontinence

Treatments

Combination Product: Practice Facilitation
Behavioral: Mobile Health Application focused on behavioral treatments to treat urinary incontinence

Study type

Observational

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT05438849
U18HS028736 (U.S. AHRQ Grant/Contract)
1658917-2

Details and patient eligibility

About

The PURSUIT project aims to improve access to evidence-based nonsurgical UI treatment for women Veterans in the Southeast region of the United States using the most effective remote delivery modality. Using cluster randomization, the study will compare two models at the practice level: (1) the use of a practice facilitation toolkit with a mHealth UI modality alone and (2) the practice facilitation toolkit with a mHealth UI model combined with education on clinical pathways for consultation. Patient level outcomes related to UI symptom improvement will be compared. Patient and provider perceptions of factors that could influence future remote UI treatment scalability will also be assessed. All primary care practices will receive practice facilitation with a PURSUIT toolkit that includes (1) 1-2 visits with a practice facilitator; (2) mobile-health or mHealth application training (MAT); 3) online resource hub; and (4) health information technology (HIT) assistance. PURSUIT's future goal is to disseminate the most effective modality for delivering nonsurgical UI treatment for women Veterans nationally within the VHA.

Full description

PURSUIT aims to recruit 62 practices to participate in the trial implementation at 50 practices. Specifically, Community-Based Outpatient Clinics (CBOCs) from VA Integrated Service Network (VISN) 7 will be targeted, spanning the states of Alabama, Georgia, and South Carolina. The project will focus on VISN 7 CBOCs, serving at least 50 women Veterans with primary care services, will be recruited through connections with local women's health providers. The team estimates outreach to approximately 50,000 women Veterans and estimates that 30 percent (n=15,000) of these women will have UI symptoms, and, among those, 15 percent (n=2,500) will participate.

Enrollment

2,500 estimated patients

Sex

Female

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Veteran
  • English-speaking, community-dwelling women Veterans
  • Diagnosis of UI (all types)
  • Access to the internet via a mobile device or computer

Exclusion criteria

Women Veterans who are currently pregnant or less than 12 weeks postpartum

Trial design

2,500 participants in 2 patient groups

Women Veterans receiving primary care in VISN-7 of the VA Healthcare Administration (VHA)
Description:
This project will include English-speaking, community-dwelling women Veterans 20 years or older with a diagnosis of UI (all types) and access to the internet via a mobile device or computer. Women Veterans who are currently pregnant or less than 12 weeks postpartum will be excluded. PURSUIT utilizes a mobile health application, called MyHealtheBladder, to connect patients with nonsurgical treatment options.
Treatment:
Behavioral: Mobile Health Application focused on behavioral treatments to treat urinary incontinence
Health care providers in community-based outpatient clinics in VISN-7 of the the VHA
Description:
Community-Based Outpatient Clinics (CBOCs) from VA Integrated Service Network (VISN) 7 will be targeted, spanning the states of Alabama, Georgia, and South Carolina. VISN 7 CBOCs, serving at least 50 women Veterans with primary care services, will be recruited.
Treatment:
Combination Product: Practice Facilitation

Trial documents
1

Trial contacts and locations

2

Loading...

Central trial contact

Hannah E Howell, MS; Janice M Phillips

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems